985 related articles for article (PubMed ID: 495673)
21. Termination of very early pregnancy by RU 486--an antiprogestational compound.
Kovacs L; Sas M; Resch BA; Ugocsai G; Swahn ML; Bygdeman M; Rowe PJ
Contraception; 1984 May; 29(5):399-410. PubMed ID: 6744860
[TBL] [Abstract][Full Text] [Related]
22. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting.
Cates W; Schulz KF; Grimes DA; Horowitz AJ; Lyon FA; Kravitz FH; Frisch MJ
JAMA; 1982 Aug; 248(5):559-63. PubMed ID: 6285012
[TBL] [Abstract][Full Text] [Related]
23. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
Schwartz NB
Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
[TBL] [Abstract][Full Text] [Related]
24. The disappearance of HCG and return of pituitary function after abortion.
Lähteenmäki P
Clin Endocrinol (Oxf); 1978 Aug; 9(2):101-12. PubMed ID: 568043
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of ovulation induction.
Wu CH
Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
[TBL] [Abstract][Full Text] [Related]
26. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of antigonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin.
Talwar GP; Singh O; Singh V; Rao DN; Sharma NC; Das C; Rao LV
Fertil Steril; 1986 Jul; 46(1):120-6. PubMed ID: 2424791
[TBL] [Abstract][Full Text] [Related]
28. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
Mandelin M
Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
[TBL] [Abstract][Full Text] [Related]
29. Maternal serum hormone changes during abortion induced with 9-deoxo-16, 16-dimethyl-9-methylene prostaglandin E2.
Bremme K; Eneroth P; Bygdeman M
J Endocrinol Invest; 1982; 5(6):387-91. PubMed ID: 7169514
[TBL] [Abstract][Full Text] [Related]
30. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
[TBL] [Abstract][Full Text] [Related]
31. Levels of HCG in subjects using the Progestasert(TM) intrauterine progesterone systems.
Custo GM; Carenza L; Pala A
Contraception; 1980 Mar; 21(3):311-7. PubMed ID: 6771092
[TBL] [Abstract][Full Text] [Related]
32. Norplant implants: the mechanism of contraceptive action.
Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
[TBL] [Abstract][Full Text] [Related]
33. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
34. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
35. Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy.
Olajide F; Howell RJ; Wass JA; Holly JM; Bohn H; Grudzinskas JG; Chapman MG; Chard T
Hum Reprod; 1989 Apr; 4(3):337-40. PubMed ID: 2715311
[TBL] [Abstract][Full Text] [Related]
36. Changes in the concentration of alpha-fetoprotein and placental hormones following two methods of medical abortion in early pregnancy.
Thong KJ; Norman JE; Baird DT
Br J Obstet Gynaecol; 1993 Dec; 100(12):1111-4. PubMed ID: 7507707
[TBL] [Abstract][Full Text] [Related]
37. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.
Romeu A; Monzó A; Peiró T; Diez E; Peinado JA; Quintero LA
J Assist Reprod Genet; 1997 Oct; 14(9):518-24. PubMed ID: 9401870
[TBL] [Abstract][Full Text] [Related]
38. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
Birgerson L; Odlind V
Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
[TBL] [Abstract][Full Text] [Related]
39. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
40. Pituitary gonadotropin response to LHRH in human pregnancy.
Rubinstein LM; Parlow AF; Derzko C; Hershman J
Obstet Gynecol; 1978 Aug; 52(2):172-5. PubMed ID: 355962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
